Cross-over Pilot Study of Blood Cholesterol Response to Dietary Saturated Fat in Patients With Autosomal Dominant Hypercholesterolemia



Status:Withdrawn
Conditions:High Cholesterol
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - 80
Updated:11/30/2018
Start Date:May 15, 2017
End Date:June 30, 2020

Use our guide to learn which trials are right for you!

Randomized, Cross-over Pilot Study of Blood Cholesterol Response to Dietary Saturated Fat in Patients With Autosomal Dominant Hypercholesterolemia

We are performing a pilot cross-over diet study involving 5 patients with heterozygous FH and
5 patients with unexplained ADH. The patients will be randomized to a low versus high
saturated fat diet for 4 weeks each. We hypothesize that patients with unexplained ADH may
have an exaggerated cholesterol response to saturated fat intake. The specific aim of this
study is to quantify the increase in LDL-C in unexplained ADH patients compared to FH
patients. The pilot study proposed here will develop preliminary data to be used for future
funding proposals of larger, randomized studies.


Inclusion Criteria:

1. Adults, age > 18 years or < 80 years

2. Pre-treatment LDL-C greater than the 95th percentile for age and sex (corresponding to
190 mg/dL for most adults), with one of the 2 following criteria: (1) tendon xanthoma
(proband or first-degree relative) or (2) either first-degree relative with premature
CHD (age less than 55 years in men or 65 years in women) or pretreatment LDL-C greater
than the 95th percentile for age and sex.

3. Willing to come off medical therapy 4 weeks before and during study.

4. Willing to follow high/low saturated fat diet

5. Willing to attend dietary counseling sessions

6. Willing to attend frequent clinic visits

7. Subjects willing to participate under the conditions described in the informed consent
form (ICF) and able to sign the ICF and applicable HIPAA forms.

Exclusion Criteria:

1. Presence of any clinically significant uncontrolled endocrine disease known to
influence serum lipids or lipoproteins. Note: patients on thyroid replacement therapy
can be included if the dosage of thyroxine has been stable for 6 weeks prior to the
first study visit and thyroid-stimulating hormone (TSH) level is within the normal
range.

2. Conditions of severe acute vascular stress (e.g. acute coronary syndrome, ischemic
stroke, or major vascular surgery) within 3 months prior to the first study visit.

3. Patients unable to maintain their current activity level or planning to increase their
activity level (e.g. new exercise regimen).

4. Pregnant or breast-feeding women.

5. Major illness

6. Secondary cause of dyslipidemia (e.g. obstructive liver disease, hypothyroidism, or
nephrotic syndrome)

7. Hospitalization within 3 months

8. Substance abuse (illegal drug use, chronic alcoholism or problematic use of alcohol or
total daily alcohol intake >2 drinks per day in men and > 1 drink per day in women).

9. Immunodeficiency or HIV-positive status

10. Illiteracy

11. Severe medical condition that may impair the ability of the person to participate in a
nutrition intervention study (e.g. digestive disease with fat intolerance, advanced
malignancy, or major neurological, psychiatric or endocrine disease)

12. Any other medical condition thought to limit survival to less than 1 year

13. Difficulties or major inconvenience to change dietary habits

14. History of food allergy with hypersensitivity to any of the components of olive oil or
nuts
We found this trial at
1
site
2201 Inwood Rd
Dallas, Texas 75235
(214) 645-8300
U.T. Southwestern Medical Center The story of UT Southwestern Medical Center is one of commitment...
?
mi
from
Dallas, TX
Click here to add this to my saved trials